Boombostic Health

Artificial intelligence has been a buzzword for years, but few leaders in healthcare are truly harnessing its potential to transform how we diagnose, treat, and ultimately save lives. Bradley Bostic, host of BoomBostic Health and CEO of hc1, recently invited Simon Arkell, CEO of Ryght AI, to explore the incredible leaps AI is making in clinical trials and diagnostics. Simon, a former Olympian turned serial entrepreneur, brings a refreshing perspective on AI's untapped capabilities in healthcare, grounded in years of experience and success.

Simon's journey from Olympic pole vaulter to AI innovator is remarkable in itself. But it's his insights into how generative AI can revamp clinical trials that truly set him apart. He explains how AI has evolved, not just as a buzzword but as a game-changing force that redefines what's possible in healthcare. Ryght AI's approach is to simplify and accelerate clinical research by connecting all the moving parts involved, creating a platform that benefits from each new advancement in AI without the technical "debt" that usually accompanies such innovation.

One of the most significant obstacles in clinical research is data fragmentation. Many biotech firms lack access to real-time data, making it difficult to connect the right patients with the right trials. Simon elaborates on how Ryght AI leverages generative AI to bridge this gap, creating a network that can process data from various sources, making trial recruitment faster and more precise. Bradley, a strong advocate for personalized care, was quick to highlight the urgent need for such a transformation. "There's a reason AI is essential here—it could mean years shaved off in bringing life-saving drugs to market," Bradley emphasized.

Simon's vision for AI goes beyond mere data processing. He explains that AI enables a more holistic approach, where clinical trials are no longer bound by outdated methods, such as manually matching patient profiles with trials. Instead, AI can predict which clinical trial sites will succeed based on historical data, patient demographics, and existing workloads. This way, clinical trials aren't just fast-tracked; they're also more effective. As Simon puts it, "We're looking to create a future-proof platform that can adapt to new AI models and leverage data without re-engineering the wheel."

The conversation then shifts to the human element in AI-driven healthcare. Simon recounts how AI, if used correctly, could reduce the burnout that often affects doctors and researchers by automating repetitive tasks and allowing them to focus on direct patient care. He imagines a future where AI doesn't replace human judgment but enhances it, giving medical professionals the time and data to make better-informed decisions.
One of the key points Simon raised was the necessity of keeping AI adaptable. Ryght AI's platform sits above the shifting landscape of AI models, allowing it to incorporate the latest and best models without a massive overhaul each time. This adaptability, as he argues, is crucial for any healthcare company looking to stay relevant. In response, Bradley acknowledged the unique challenges and pointed out that "AI in healthcare isn't just a trend; it's a strategic advantage for those ready to evolve."

In closing, Bradley expressed admiration for Ryght AI's mission, describing it as a "turbocharger" for clinical research. With the support of healthcare giants and innovative AI, Simon is optimistic about a future where clinical trials are faster, more accessible, and far more accurate. He envisions a time when life-saving treatments are developed not in decades but in years, a transformation he believes AI will make possible.

In the latest episode of the BoomBostic Health Podcast, Bradley Bostic sat down with Liz Hutson, a healthcare consultant with over 25 years of experience, to explore the intricacies of mergers and acquisitions (M&A) in healthcare. Together, they uncovered strategies for navigating the complexities of consolidation while maximizing patient outcomes and organizational value.

At its core, M&A in healthcare is about creating partnerships that improve care delivery and expand access to critical resources. Liz emphasized that every merger begins with purpose—leaders must ask, "How will this benefit the patient?" This question drives not only strategic decisions but also the trust and alignment necessary for a successful transition.

Liz's proven SMSO framework—Stabilize, Mobilize, Stabilize, Optimize—has guided countless organizations through the challenges of integration. The process begins with strengthening both entities before any change occurs, ensuring they can withstand the demands of consolidation. "Stability is non-negotiable," Liz explained. "Without it, even the best opportunities can crumble under pressure."

Once stabilization is achieved, mobilization focuses on the careful execution of the transition. Clear communication and thoughtful planning are vital during this phase. Liz stressed the importance of empathy, particularly when addressing the emotional impact of change on employees. "People are the intellectual capital you're acquiring," she said. "Their buy-in determines the success of the entire process."

Following mobilization, the framework emphasizes restabilizing the combined organization to ensure operational continuity before moving into optimization. "It's tempting to aim for immediate efficiency gains," Liz acknowledged. "But patience pays off—jumping too soon adds unnecessary risk."

Bradley highlighted the significance of cultural alignment in M&A, reflecting on his own experience at hc1. He shared that fostering collaboration between teams and ensuring a values-driven approach were critical to the success of past acquisitions. "Without culture fit, even the most strategic mergers can fall apart," he noted.

Regulatory challenges also play a significant role in healthcare M&A. Liz emphasized the need for thorough preparation, including compliance audits and proactive due diligence. By addressing potential vulnerabilities early, organizations can avoid costly delays and maintain trust with stakeholders.

Throughout the episode, Liz and Bradley stressed the importance of tying every decision back to patient impact. Whether scaling operations or integrating cutting-edge technology, the end goal should always be improving care. This perspective not only drives innovation but also reinforces the mission of healthcare as a deeply human endeavor.

Their discussion underscored that success in M&A isn't just about numbers on a spreadsheet—it's about building something greater than the sum of its parts. Leaders who prioritize vision, empathy, and disciplined execution can unlock the full potential of their partnerships and create lasting value for patients and organizations alike.

The healthcare industry is undergoing a seismic shift as artificial intelligence (AI) and cybersecurity redefine the landscape. While AI promises breakthroughs in patient care and operational efficiency, it also brings challenges that demand careful navigation. At the heart of these conversations are leaders like Bradley Bostic, an innovator driving change in personalized medicine, and Nick Merker, a privacy, cybersecurity, and AI expert with a deep understanding of healthcare's regulatory complexities.

Nick's unconventional journey—from computer science to law to healthcare—offers a unique lens on these pressing issues. His technical expertise, coupled with a legal and ethical approach, underscores the importance of transparency and responsibility in implementing AI. "AI in healthcare isn't just a technology—it's a trust mechanism," Nick emphasizes. "Transparency in how AI systems are built and maintained is non-negotiable, especially when they influence life-altering decisions."

The regulatory landscape for AI is still taking shape, but some frameworks, like the European Union's AI Act, are emerging as global benchmarks. The EU AI Act categorizes AI systems by risk, imposing stricter requirements on those deemed "high-risk," such as healthcare applications. Nick predicts this model will influence policies worldwide. "Much like the GDPR transformed privacy laws globally, the EU AI Act is setting the foundation for how AI is governed across industries," he explains.

The conversation around AI in healthcare isn't just about rules—it's also about ethics and practical implementation. AI's dynamic nature makes it challenging to regulate, as it evolves based on data inputs and usage patterns. Nick argues that transparency and robust monitoring mechanisms will be key. "AI must be designed with accountability baked in. It's not about preventing issues entirely but about having systems in place to identify and resolve them quickly when they arise."

Cybersecurity is another critical area where healthcare must advance rapidly. The industry's reliance on interconnected systems and vast amounts of sensitive data makes it an attractive target for cyberattacks. The consequences of a breach go beyond financial losses—patient safety and trust are on the line.

The ransomware attack on a prominent healthcare billing company is a stark reminder of these vulnerabilities. The attack disrupted cash flow for nearly 91% of U.S. healthcare providers, forcing some to take drastic measures to keep their doors open. "Continuity planning isn't just a good practice—it's a necessity," Nick says. "Healthcare providers must rethink their reliance on single points of failure, especially in critical areas like billing and patient data management."

Practical steps include developing contingency plans, conducting regular "tabletop exercises" to simulate potential breaches, and diversifying vendor relationships. "Organizations need to treat cybersecurity with the same seriousness they apply to patient care," Nick advises. "If your systems go down, your ability to provide care is compromised—that's unacceptable in a field where lives are at stake."

Despite these challenges, both Nick and Bradley remain optimistic about the future of healthcare. They view AI as an enabler rather than a disruptor. "AI won't replace people—it will empower them," Nick asserts. "It's about using technology to enhance human capabilities, not diminish them." Bradley shares this perspective, emphasizing that AI's ultimate promise lies in its ability to make healthcare more personalized, efficient, and equitable.

Cybersecurity has become a defining issue in modern healthcare, with attackers targeting critical systems that directly affect patient safety. The shift from early cyberattacks, which focused on stealing personal information, to ransomware-driven models has introduced a new level of urgency. Healthcare institutions must now contend with sophisticated ransomware-as-a-service operations that function like legitimate businesses, complete with software developers, negotiators, and pricing models.

This evolution presents significant challenges for an industry where operational continuity can mean the difference between life and death. Unlike other sectors, healthcare organizations face unique pressures. When systems are down, it's not just a matter of lost revenue—it's about protecting lives. For example, losing access to patient records in an emergency setting can have catastrophic consequences, making healthcare institutions particularly likely to comply with ransom demands.

The vulnerabilities in the healthcare sector are often exacerbated by reliance on outdated infrastructure. Many organizations depend heavily on a small number of vendors, some of which have legacy systems that are difficult to secure. This overreliance creates systemic risks, as any disruption to these vendors can ripple across the entire industry. Diversifying vendor relationships and modernizing technology are essential steps toward mitigating these risks.

To navigate these challenges, healthcare leaders must adopt robust business continuity strategies. This involves planning for disruptions not only within their own systems but also across their supply chains. Regularly testing incident response plans and ensuring redundancies are in place can help organizations recover more quickly from attacks. As one expert noted, business continuity is about preparing for the unexpected, whether it's a ransomware attack, a natural disaster, or a supply chain failure.

Emerging technologies offer promising solutions but also come with their own set of challenges. Blockchain, for instance, has been proposed as a way to secure medical records through decentralization. While the concept is compelling, its implementation raises questions about accessibility and vulnerability. What happens if a patient loses their access key? Or if a large-scale attack compromises the network? These are the kinds of issues healthcare leaders must consider when exploring new technologies.

In addition to technical strategies, leaders must stay ahead of the rapidly evolving regulatory landscape. Consumer health data, particularly from wearable devices, is generating unprecedented amounts of information. Unlike traditional medical records, much of this data exists outside the protections of HIPAA. While federal and state laws are beginning to address these gaps, the regulatory framework remains a patchwork, leaving room for ambiguity and risk.

Proactive governance is critical. Healthcare organizations must ensure they are not only compliant with existing laws but also adopting ethical practices around data usage. This includes educating patients about how their data is collected and used, as well as implementing strong safeguards to protect against breaches.

The growing intersection of healthcare and consumer technology also presents opportunities for innovation. Wearable devices and AI-powered analytics are enabling more personalized care, from early detection of chronic conditions to real-time health monitoring. These advancements could revolutionize the industry, but they require careful integration with existing systems to avoid creating new vulnerabilities.

Join us for an insightful episode of Boombostic Health as we sit down with Dev Kalyan, a multifaceted leader in healthcare innovation. From his unique journey as a surgeon, attorney, and veteran to his groundbreaking work with the Veterans Administration Health System, Dev shares his vision for transforming veteran care. Discover how his company, 4th Sector, is driving innovation with a $650 million initiative and learn about the challenges and opportunities in creating a more effective healthcare system for veterans. Tune in to explore bold ideas and be part of the conversation on reshaping the future of healthcare.